Jianguo SunQin JiangXiao‐Pei ZhangK. Y. ShanBai-Hui LiuChen ZhaoBiao Yan
This study provides a novel strategy of encapsulating bevacizumab to protect and deliver it, which could increase the time between administration and formulation shelf-life. MSN-encapsulated bevacizumab is a promising drug delivery alternative of antiangiogenic therapy.
Safia NazMingyu WangYuning HanBin HuLiping TengJuan ZhouHuijie ZhangJinghua Chen
Zhengzou FangXinyuan LiZeyan XuF. DuWendi WangRuihua ShiDaqing Gao
Marine Le GoasM. PaquetAurélie PaquirissamyJulien GuglielmiCathy CompinJuliette ThariatGeorges VassauxValérie GeertsenOlivier HumbertJean‐Philippe RenaultGéraldine CarrotThierry PourcherBéatrice Cambien
Catarina Roma‐RodriguesAlexandra R. FernandesPedro V. Baptista
Shawqi H. AlawdiHousam EidiMarwa M. SafarMosaad A. Abdel‐Wahhab